There is a CNBC story out today about "Business confidence booming." iStock guesses that it all depends on how you define booming. The survey of 33 chief financial officers (CFO) from Europe and Asia found, "The overwhelming majority of respondents-65 percent-see the global economy modestly improving over the next six months, with 4 percent seeing it "strongly improving" over the same period."
However, the CNBC survey showed, "Over 80 percent of respondents had fears over slowing growth to some degree. Just 9 percent indicated that they were unconcerned."
In the same story, it's noted that the International Monetary Fund (IMF) has a "growth estimate for developed countries - including the euro area, the U.S., U.K., Japan and Canada - at 1.2 percent in 2013 and 2.0 percent in 2014."
Top 10 Energy Stocks For 2015: Nevsun Resources Ltd (NSU)
Nevsun Resources Ltd. is a Canadian mineral resource company. The Company, through its subsidiaries is engaged in the acquisition, exploration, development, and production of mineral properties. Its primary operating asset is the Bisha Mine located on the Bisha Property with gold, silver and base metal (copper and zinc) mineral resources and mineral reserves. In addition, the Company owns the Mogoraib exploration license containing 97.4 square kilometers of area located 16 kilometers southwest of the Bisha Mine, and a mining licence for the Harena deposit, located approximately 9 kilometers south of the Bisha Mine. The Bisha Mine is owned by BMSC, the voting securities of which are held 60% by the Company and 40% by ENAMCO. During the year ended December 31, 2012, diamond drilling programs were undertaken across Bisha Main, Bisha Hangingwall (HW) Copper, Harena and the Northwest (NW) Zone, for a total of approximately 115 holes and 19,432 meters. Advisors' Opinion:- [By Rich Smith]
In a terse, 101-word announcement, Vancouver-based and Eritrea-operating gold-mining company Nevsun Resources (NYSEMKT: NSU ) announced the departure of its CFO on Wednesday.
Hot Healthcare Equipment Stocks To Invest In Right Now: Northwest Bancshares Inc.(NWBI)
Northwest Bancshares, Inc. operates as the holding company for Northwest Savings Bank that offers various banking and consumer finance services. The company offers consumer and commercial deposits, such as checking accounts, savings accounts, money market deposit accounts, term certificate accounts, and individual retirement accounts. Its loan portfolio comprises one- to four-family residential real estate loans, multifamily residential and commercial real estate loans, home equity loans and lines of credit, and commercial business loans, as well as consumer loans, including automobile loans, sales finance loans, unsecured personal loans, credit card loans, and loans secured by deposit accounts. It also offers trust, investment management, actuarial and benefit plan administration, brokerage services, title insurance, and municipal bonds, as well as involves in the ownership and operation of properties. As of December 31, 2009, the company operated 171 community-banking of fices in northwest, southwest, and central Pennsylvania; western New York; eastern Ohio; Maryland; and southeastern Florida. It also operated 51 consumer finance offices in Pennsylvania. The company was founded in 1896 and is headquartered in Warren, Pennsylvania.
Advisors' Opinion:- [By Rich Duprey]
Northwest Bancshares (NASDAQ: NWBI ) announced today that it will be paying a special dividend of $0.12 per share in May to�supplement the regular dividend for the first quarter of 2013, which it prepaid back in December in a bid to�accelerate the distribution of cash�to help shareholders offset some of the risk of higher taxes.
Hot Healthcare Equipment Stocks To Invest In Right Now: Taro Pharmaceutical Industries Ltd (TARO)
Taro Pharmaceutical Industries Ltd., incorporated in 1959, is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs), primarily for use in its finished dosage form products. The Company�� primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three companies: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries (including indirect), Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 25 countries.
Taro Israel manufactures more than 160 finished dosage form pharmaceutical products for sale in Israel and for export. It produces APIs used in the manufacture of finished dosage form pharmaceutical products. It markets and distributes generic products in the local Israeli market. Taro Israel�� primary product lines include dermatology, prescription and OTC semi-solid products (creams, ointments and gels) and liquids; cardiology and neurology, prescription oral dosage products; oral analgesics, both prescription and OTC, and OTC oral and nasal sprays and ophthalmic products.
Taro Canada manufactures more than 70 finished dosage form pharmaceutical products for sale in Canada and for export. It markets and distributes generic products in the local Canadian market. Its product line includes dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology, oncology, gastrointestinal and neurology: prescription oral and injects able dosage products, and allergy (antihistamine): OTC oral dosage products.
Taro U.S.A markets! and distributes generic products in the United States market. Its primary product lines include dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology and neurology: prescription oral dosage products, and other prescription and OTC products.
The Company competes with Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer/Wyeth, Valeant, Galderma, Merck/Schering-Plough, Teva Pharmaceuticals U.S.A., Mylan Laboratories, Perrigo Company, Ranbaxy Pharmaceuticals Inc., Sandoz Pharmaceuticals, Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Schering-Plough Canada, Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Bayer Inc., Bristol-Myers Squibb Canada, Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated, Pharmascience Inc., Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexxon Ltd., Rafa Laboratories Ltd., Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc.
Advisors' Opinion:- [By Ben Levisohn]
Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.
- [By Rich Smith]
Israeli drugmaker Taro Pharmaceutical Industries (NYSE: TARO ) has a new CEO -- and a new Chairman of the Board, as well.
On Thursday, Taro announced the imminent retirement of Interim Chief Executive Officer Mr. James Kedrowsk, who will be replaced August 1 by new permanent CEO Mr. Kalyanasundaram Subramanian ("Kal Sundaram"). Additionally, the company said that Dilip Shanghvi�has been appointed Chairman of its Board of Directors.
Hot Healthcare Equipment Stocks To Invest In Right Now: Pharmerica Corporation(PMC)
Pharmerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. It also provides consultant pharmacist services for customers to comply with the federal and state regulations applicable to nursing homes; and medical records services. In addition, the company offers various ancillary services, such as infusion therapy products and services; and hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs to various hospitals. PharMerica Corporation operates approximately 95 institutional pharmacies in 44 s tates and provides pharmacy management services to 91 hospitals. Its customers primarily include institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. The company is headquartered in Louisville, Kentucky.
Advisors' Opinion:- [By Sean Williams]
What: Shares of PharMerica (NYSE: PMC ) , a pharmacy services company, jumped as much as 11% after reporting better-than-expected first-quarter results.
- [By Josh Arnold]
PharMerica Corporation (PMC) is a pharmacy services company that operates in several segments in the US. The company offers services to healthcare facilities, pharmacy management services and specialty infusion to patients outside of hospitals. PMC's primary customers are assisted living centers, hospitals, and other long term care facilities. The company services just under 200 locations in 45 states in the US and produces about $1.7 billion in annual revenue. With shares near the bottom of their 52 week range following a nasty selloff, is there any value in PMC or is it a classic trap? I'll argue here that PMC's structural tailwinds for earnings including demographics and consumer preference shifts will increase PMC's ability to convert revenue into profit and drive the stock higher.
Hot Healthcare Equipment Stocks To Invest In Right Now: Daily Mail and General Trust PLC (DMGT)
Daily Mail and General Trust PLC (DMGT) is a United kingdom-based multi-media and information company. The Company�� business activities are split into seven operating segments: RMS, business information, events, Euromoney, national media, local media and radio. Its dmg information is a business information division, providing business to business (B2B) information to the property, financial, energy and educational recruitment markets. As of October 2, 2011, dmg events, its business-to-business (B2B) exhibition and conferences division, operated 27 exhibitions and two conference businesses. Euromoney Institutional Investor PLC is a B2B media group. Associated Newspapers is its newspaper division. In September 2012, it sold its remaining 50% interest in DMG Radio Australia to Illyria. In July 2013, Daily Mail and General Trust PLC announced that Rothermere Continuation Limited has a holding 89.2% of interest of the Company. Advisors' Opinion:- [By Inyoung Hwang]
Daily Mail & General Trust Plc (DMGT) climbed 2.4 percent to 861 pence. The company said contribution from national newspapers to the group�� revenue dropped to 36 percent this year from 43 percent in 2012 and will fall further. The publisher of Britain�� second-biggest U.K. daily newspaper forecast full-year revenue will be 1.8 billion pounds, matching analysts�� estimates.
Hot Healthcare Equipment Stocks To Invest In Right Now: BKI Investment Company Ltd (BKI)
BKI Investment Company Limited, operates in the securities industry in Australia. The Company invests in a diversified portfolio of Australian shares, trusts and interest bearing securities. The Company�� investment objective is to generate an increasing income stream for distribution to its shareholders in the form of fully franked dividends, to the extent of its available imputation tax credits, through long-term investment in a portfolio of assets that are also able to deliver long term capital growth to shareholders. During the fiscal year ended June 30, 2012, the Company invested $26.5 million into the market with major purchases including Westpac Banking Corporation, National Australia Bank, Wesfarmers Limited and Fleetwood Corporation. The Company also divested a number of holdings including BlueScope Steel, Echo Entertainment, Transfield Services, Suncorp Metway Preference Shares, Westpac Preference Shares (WBCPA) and half of the position in Westpac Preference Shares (WBCPB). Advisors' Opinion:- [By Chris Hill]
In this installment of Motley Fool Money, our analysts explain why they're watching Buckeye Technologies (NYSE: BKI ) , Bristow Group (NYSE: BRS ) , and Western Union (NYSE: WU ) .
Hot Healthcare Equipment Stocks To Invest In Right Now: CTS Corporation (CTS)
CTS Corporation engages in the design, manufacture, assembly, and sale of electronic components and sensors, as well as the provision of electronics manufacturing services. It offers automotive sensors and actuators used in commercial or consumer vehicles; electronic components used in communications infrastructure and computer markets; components used in computer and other high-speed applications, switches, resistor networks, and potentiometers; and fabricated piezoelectric materials and substrates used primarily in medical, industrial, defense and aerospace, and computer markets. The company markets and sells its products through its sales engineers, independent manufacturers� representatives, and distributors. It has operations in China, Japan, Scotland, Singapore, India, Taiwan, and the United States. CTS Corporation was founded in 1896 and is based in Elkhart, Indiana.
Advisors' Opinion:- [By Marc Bastow]
When earnings reports roll in, so do the dividend increases. This week, we saw a veritable tidal wave of dividend increases, from Megacap stocks like Halliburton (HAL) and Whole Foods (WFM) to smaller players like� CTS Corporation (CTS), companies were scrambling to boost their dividend payouts. A total of 23 companies increased their dividends this week.
- [By Seth Jayson]
CTS (NYSE: CTS ) reported earnings on July 22. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), CTS missed estimates on revenues and beat expectations on earnings per share.
No comments:
Post a Comment